Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolised salbutamol dosing in preterm infants with developing bronchopulmonary dysplasia
2009-010381-30Phase 4Active
- Sponsor
- Isala
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of salbutamol in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by Isala. Primary endpoint: Change in plasma potassium. Started Jun 2009; status: active.
02
Drugs
salbutamol
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on 2009-010381-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010381-30.